WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011019417) PYRIDO [4, 3-B] INDOLES AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/019417    International Application No.:    PCT/US2010/033055
Publication Date: 17.02.2011 International Filing Date: 29.04.2010
IPC:
A01N 43/42 (2006.01)
Applicants: MEDIVATION TECHNOLOGIES, INC. [US/US]; 201 Spear Street, 3rd Floor San Francisco, CA 94105 (US) (For All Designated States Except US).
JAIN, Rajendra, Parasmal [IN/IN]; (IN) (For US Only).
CHAKRAVARTY, Sarvajit [US/US]; (US) (For US Only)
Inventors: JAIN, Rajendra, Parasmal; (IN).
CHAKRAVARTY, Sarvajit; (US)
Agent: REANEY, Shannon; Morrison & Foerster LLP 755 Page Mill Road Palo Alto, CA 94304-1018 (US)
Priority Data:
61/181,259 26.05.2009 US
1135/MUM/2009 29.04.2009 IN
Title (EN) PYRIDO [4, 3-B] INDOLES AND METHODS OF USE
(FR) PYRIDO[4,3-B]INDOLES ET LEURS MÉTHODES D'UTILISATION
Abstract: front page image
(EN)New heterocyclic compounds that may be used to modulate a histamine receptor in an individual are described. Pyrido[4,3-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
(FR)L'invention concerne de nouveaux composés hétérocycliques pouvant être utilisés pour moduler un récepteur de l'histamine chez un individu. Elle concerne des pyrido[4,3-b]indoles ainsi que des compositions pharmaceutiques comprenant ces composés et des méthodes d'utilisation desdits composés dans diverses applications thérapeutiques, et notamment dans le traitement d'un trouble cognitif, d'un trouble psychotique, d'un trouble médié par un neurotransmetteur et/ou d'un trouble neuronal.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)